CF PHARMTECH, INC. - H SHARES
(HKEX: 2652)
CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. The company focuses on complex products and platforms, innovative medicines, and medical devices. It also offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. The company was founded by Liang Wenqing and Li Li in 2007 and is headquartered in Suzhou, China.
37.700 -
+0.560
(+1.51%)
Range
36.260 - 37.780
(4.19%)
Open
37.000
Previous Close
37.140
Bid Price
37.580
Bid Volume
('000)
1.5
Ask Price
37.700
Ask Volume
('000)
0.5
Volume
('000)
125
Value
4,646,810
Remark
-
Delayed prices. Updated at 05 Dec 2025 14:52.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
